Wageningen University and Research
Wageningen, Gelderland, 6708 WD, Netherlands
NCT Number: NCT06218264
The present study aims to quantify the insulin sensitivity and the skeletal muscle protein synthetic response to consuming a test drink containing all amino acids or all amino acids except for BCAAs.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Wageningen, Gelderland, 6708 WD, Netherlands
Twenty-eight healthy, young volunteers will receive a stable isotope tracer infusion (7.5h) combined with repeated blood and muscle sampling, to measure muscle protein synthesis rate in the postabsorptive state following ingestion of a drink containing all amino acids (n=14) or all amino acids except for BCAAs (n=14).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral intake of a supplement containing amino acids
Time frame: 4 hours
Muscle protein synthesis rate (FSR) prior to and following ingestion of an amino acid drink
Time frame: 7.5 hours
Insulin sensitivity, measured as forearm glucose uptake, prior to and following ingestion of an amino acid drink
Time frame: Four hours following ingestion of an amino acid drink
Whole-body insulin sensitivity, calculated using a modified Matsuda index
Time frame: Prior to and for 4 hours following amino acid intake
Plasma phenylalanine kinetics using a stable isotope tracer infusion
Wageningen University
Other
The Role of Branched-chain Amino Acids (BCAAs) in the Stimulation of Skeletal Muscle Protein Synthesis and Glucose Uptake in Healthy Young Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details